These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Inhibitors and activation markers of the haemostatic system during hormone therapy: a comparative study of oral estradiol (2 mg)/ dydrogesterone and estradiol (2 mg)/ trimegestone. Norris LA, Brosnan J, Bonnar J, Conard J, Kluft C, Hellgren M. Thromb Haemost; 2008 Aug; 100(2):253-60. PubMed ID: 18690345 [Abstract] [Full Text] [Related]
19. Differential effect of the ultra-low dose and standard estrogen plus dydrogesterone therapy on thrombin generation and fibrinolysis in postmenopausal women. Piróg M, Jach R, Kacalska-Janssen O. Acta Obstet Gynecol Scand; 2017 Dec; 96(12):1438-1445. PubMed ID: 28981954 [Abstract] [Full Text] [Related]